Health Canada updates Pfizer-BioNTech COVID-19 vaccine label to reflect very rare reports of Bell's Palsy

Health Canada has updated the product information for the Pfizer-BioNTech COVID-19 vaccine to describe very rare reports of Bell’s Palsy (typically temporary weakness or paralysis on one side of the face) following vaccination.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 21:42 (TU)
Créé le avril 17, 2026, 21:42 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-08-06 00:00:00
open_canada_keywords {"fr": ["COVID-19", "étiquette du vaccin COVID-19", "mises à jour du vaccin Pfizer-BioNTech", "Bell's Palsy", "rapports rares", "vaccins COVID-19", "vaccin sûr et efficace"], "en": ["COVID-19", "COVID-19 vaccine label", "updates Pfizer-BioNTech vaccine", "Bell's Palsy", "rare reports", "COVID-19 vaccines", "safe and effective vaccine"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Santé Canada met à jour l'étiquette du vaccin contre la COVID-19 de Pfizer-BioNTech pour mentionner les très rares signalements de paralysie de Bell
update_frequency as_needed